Vedanta Biosciences closes extended $45.5 million Series C funding

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based ...

May 13, 2019 | Monday | News
Transgene receives FDA IND clearance for Ph1 trial of lead myvac

Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of solid tumor...

May 13, 2019 | Monday | News
Boston Scientific to acquire Vertfilex for $465M

Boston Scientific has announced that it has entered into a definitive agreement to acquire Vertiflex, Inc., a priva...

May 13, 2019 | Monday | News
FDA approves heart murmur detection device

Canada based medical technology firm eMurmur has received the US Food and Drug Administration (FDA) approval for its fla...

May 10, 2019 | Friday | News
BIO continues partnership with NIH for fifth Innovation Zone exhibit

The Biotechnology Innovation Organization (BIO) and the National Institutes of Health (NIH) have announce...

May 9, 2019 | Thursday | News
WISE enrolls first patient in pivotal clinical study of novel neuro-electrodes for brain monitoring

WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring and neuromodulation,...

May 8, 2019 | Wednesday | News
AstraZeneca’s Calquence phase III ASCEND trial meets positive result

AstraZeneca announced positive results from the phase III ASCEND trial of Calquence (acalabrutinib) in previously-treate...

May 8, 2019 | Wednesday | News
Allergy Therapeutics publishes new research illustrating Group's adjuvant systems portfolio

Allergy Therapeutics, the fully integrated commercial biotechnology company specialising in allergy vaccines has an...

May 7, 2019 | Tuesday | News
Medtronic receives FDA approval for CareLink SmartSync Device Manager

Medtronic has announced that the company has received U.S. Food and Drug Administration (FDA) approval for the CareLink ...

May 7, 2019 | Tuesday | News
FDA approves treatment for rare heart disease

The U.S. Food and Drug Administration (FDA) has approved Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) capsule...

May 7, 2019 | Tuesday | News
SIME completes study validating clinical AI platform in RDS

SIME, a Clinical AI company generating unique biological data to deliver life-saving solutions, announced the publicatio...

May 6, 2019 | Monday | News
FBI approves Verogen's Next-Gen Forensic DNA technology for National DNA Index System

Verogen Inc., the world’s first DNA sequencing company dedicated to forensic science has announced that the United...

May 6, 2019 | Monday | News
FDA approves Genentech's Kadcyla

Genentech, a member of the Roche Group has announced that the U.S. Food and Drug Administration (FDA) has approved Kadcy...

May 6, 2019 | Monday | News
Prima-Temp announces new leadership, investment and CE Mark certification

Prima-Temp, Inc. a developer and manufacturer of AI-assisted fertility management products, has announced  that in ...

May 3, 2019 | Friday | News
DarioHealth partners with the American Diabetes Association

Global digital therapeutics innovator, DarioHealth Corp. announced that it is partnering with the American Diabetes Asso...

May 3, 2019 | Friday | News
NIH names Dr. Debara L. Tucci as the next director of NIDCD

National Institutes of Health Director Francis S. Collins, M.D., Ph.D., has selected Debara L. Tucci, M.D., M.S., M.B.A....

May 3, 2019 | Friday | News
binx health gets CE Mark for Rapid CT/NG test for mass markets

binx health™, the pioneer in anywhere care has announced that its proprietary Chlamydia and Gonorrhea (CT/NG) test...

May 2, 2019 | Thursday | News
Agilent, SomaLogic sign agreement for supply of custom microarrays

Agilent Technologies and  SomaLogic have announced a multi-year supply agreement whereby Agilent will sup...

May 2, 2019 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls